116 related articles for article (PubMed ID: 15371688)
1. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation.
Bock A; Bliss RL; Matas A; Little JA
Transplantation; 2004 Sep; 78(5):775-8. PubMed ID: 15371688
[TBL] [Abstract][Full Text] [Related]
2. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
3. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
4. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
5. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
6. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
[No Abstract] [Full Text] [Related]
7. HLA alleles in renal transplant recipients with nonmelanoma skin cancer in southeastern Brazil.
Rogel CS; Souza-Santana FC; Marcos EVC; Ogawa MM; Basso G; Tomimori J
An Bras Dermatol; 2019 Jul; 94(3):287-292. PubMed ID: 31365656
[TBL] [Abstract][Full Text] [Related]
8. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
9. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
[TBL] [Abstract][Full Text] [Related]
10. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
11. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
[No Abstract] [Full Text] [Related]
12. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
13. Association Between HLA Type and Skin Cancer in Kidney Transplant Recipients.
Cegielska A; Dębska-Ślizień A; Moszkowska G; Imko-Walczuk B; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1608-10. PubMed ID: 27496455
[TBL] [Abstract][Full Text] [Related]
14. Positivity for HLA DR1 is associated with basal cell carcinoma in renal transplant patients in southern Brazil.
de Carvalho AV; Bonamigo RR; da Silva CM; Pinto AC
Int J Dermatol; 2012 Dec; 51(12):1448-53. PubMed ID: 23171011
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for cutaneous warts in renal transplant recipients.
Barba A; Tessari G; Talamini G; Chieregato GC
Nephron; 1997; 77(4):422-6. PubMed ID: 9434064
[TBL] [Abstract][Full Text] [Related]
16. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
[TBL] [Abstract][Full Text] [Related]
18. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
20. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
Middleton D; Martin J; Magee BA; Douglas JF
Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
[No Abstract] [Full Text] [Related]
[Next] [New Search]